Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Pharmaceutical Contract Manufacturing
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. API/Bulk Drugs, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$94.8 Billion by ... Read More
-
Pharmaceutical Glass Packaging
... by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Glass Bottles, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$10.5 Billion by ... Read More
-
Efficacy Testing
... at a CAGR of 10.4% over the analysis period 2023-2030. Efficacy Testing Consumables, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$713.2 Million by the end ... Read More
-
Over the Counter (OTC) Drugs - Market Insight, Competitive Landscape, and Market Forecast - 2030
... Topical Creams & Ointments, and Others), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR ... Read More
-
Anti-Infective Drugs- Market Insights, Competitive Landscape, and Market Forecast - 2030
... Topical, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to ... Read More
-
Pharmaceutical Packaging Equipment
... by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Primary Packaging Equipment, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$16.7 Billion ... Read More
-
Analgesics - Market Insights, Competitive Landscape, and Market Forecast - 2030
... (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence ... Read More
-
North America Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-Sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Country 2024-2032
... The North America pharmaceutical contract packaging market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% ... Read More
-
Pain Management Drugs Market By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics) , By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain/Strain, Bone Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033 Pain Management Drugs Market The pain management drugs market was valued at $72.6 billion in 2023 ... Read More
-
Cold Chain Packaging Market Report by Product (Insulated Container and Boxes, Crates, Cold Packs, Labels, Temperature Controlled Pallet Shippers), End User (Food, Dairy, Pharmaceutical, and Others), and Region 2024-2032
... size reached US$ 27.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 68.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.52% during 2024-2032. The significant expansion in the ... Read More
-
Global Transdermal Scopolamine Market Research Report 2024(Status and Outlook)
... exhibiting a CAGR of 4.60% during the forecast period. This report provides a deep insight into the global Transdermal Scopolamine market covering all its essential aspects. This ranges from a macro overview of the market ... Read More
-
Contract Research Outsourcing
... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$61.2 Billion ... Read More
-
Global Lyophilized Reagent Beads Market Research Report 2024
... of 10.98% during the forecast period 2024-2030. North American market for Lyophilized Reagent Beads is estimated to increase from $ 111.73 million in 2023 to reach $ 224.94 million by 2030, at a CAGR of ... Read More
-
Empty Capsules Market Report by Type (Gelatin Capsule, Non-gelatin Capsule), Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl Methylcellulose (HPMC), and Others), Functionality (Immediate-release Capsules, Sustained-release Capsules, Delayed-release Capsules), Therapeutic Application (Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Cardiovascular Therapy Drugs, and Others), End User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, and Others), and Region 2024-2032
... Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Cardiovascular Therapy Drugs, and Others), End User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, and Others), and Region 2024-2032 The global empty capsules market size reached US$ 3.1 ... Read More
-
North America Healthcare Packaging Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032
... reach US$ 85.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. Healthcare packaging is utilized for providing protection to and information about any medical device or pharmaceutical product. It safeguards the ... Read More
-
Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033
... at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033. The synthetic hormones market is advancing due to significant developments ... Read More
-
Europe Highly Potent API Market - Analysis and Forecast, 2023-2033
... 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033. The primary factors propelling the expansion of the highly potent API market are the rising incidence of cancer, which boosts the demand for ... Read More
-
Two-Piece Empty Hard Capsule Market Research Report Information by Raw Material (Gelatin Hydroxypropyl Methylcellulose (HPMC), Starch and Pullulan), By size (Size "00" capsules, Size "0" capsules, Size "1" capsules, Size "2" capsules, others), By End Users (Pharmaceutical Companies, Health & Nutrition, Others) And by Region (North America, Europe, Asia-Pacific, And Rest of The World) – Industry Forecast Till 2032
... Users (Pharmaceutical Companies, Health & Nutrition, Others) And by Region (North America, Europe, Asia-Pacific, And Rest of The World) – Industry Forecast Till 2032 The Two-Piece Empty Hard Capsule Market was valued at USD 1.13 ... Read More
-
Global Cyanocobalamin API Market Growth 2024-2030
... API is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Cyanocobalamin API market. Cyanocobalamin API ... Read More
-
Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin (HPMC, Starch)), Functionality (Immediate-release, Sustained-Release, Delayed-release),Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) - Global Forecast to 2029
... 4.2 billion by 2029 from an estimated USD 3.1 billion in 2024, at a CAGR of 6.3% during the forecast period. This market's growth can be attributed to the growth in the pharmaceutical market, the ... Read More
-
Global Pharmaceutical Grade Sorbitol Market Growth 2024-2030
... the Pharmaceutical Grade Sorbitol is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Pharmaceutical Grade ... Read More
-
2024 Global: Non-Alcoholic Steatohepatitis Treatment Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 North America Pharmaceutical Contract Development And Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the Pharmaceutical Contract Development and Manufacturing industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. ... Read More
-
2024 France Pharmaceutical Contract Development And Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... the Pharmaceutical Contract Development and Manufacturing industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates ... Read More
-
2024 United Kingdom Pharmaceutical Contract Development And Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the Pharmaceutical Contract Development and Manufacturing industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. ... Read More